Abstract:Background and purpose: Multidrug resistance of tumor cells is the main factor for the failure of chemotherapy. It is found that the apigenin has the anti-tumor effect, but its role in multidrug resistant cells was rarely reported. This study aimed to investigate the effect of apigenin on multidrug resistant breast cancer cell line MCF-7/ADR, and to explore the role of apigenin in reversing multidrug resistance. Methods: The MCF-7/ADR cells were cultured with different concentrations of apigenin, and the same cells were cultured with ADR in the control group. Thecell proliferation was detected by MTT, the cell cycle distribution was detected by PI, and the cell apoptosis was detect-ed by Annexin V/PI. The drug sensitivity in vitro was detected by the method of MTT, and the drug retention rate was detected by rhodamine 123 accumulation. The expression of P-gp protein was measured by Western blot, the RT-PCR method was used to detect the transcription of multidrug resistance gene MDR1. Results: The MCF-7/ADR cell prolif-eration was inhibited by the apigenin, the cell cycle progression was blocked by the apigenin, and the cell apoptosis was induced by the apigenin. There were significant differences between the apigenin group and the ADR group (P<0.05). The IC50 of ADR on MCF-7/ADR cell was (12.37±0.18) μg/mL with the apigenin effect, while the IC50 of ADR on MCF-7/ADR cell was (39.83±0.29) μg/mL without the apigenin effect (P<0.05). The reversal index was 3.22. The retention rate of rhodamine 123 in MCF-7/ADR cells in the apigenin group was higher than that in the ADR group. The MDR1 gene transcription level in MCF-7/ADR cells was higher than that in the MCF-7 cells, and the P-gp expression in MCF-7/ADR cells was higher than that in the MCF-7 cells. However, the level of MDR1 gene transcription and P-gp expression were down-regulated by the apigenin in the MCF-7/ADR cells. Conclusion: The apigenin had anti-MCF-7/ADR effect, and played the role of reversing multidrug resistance in the MCF-7/ADR cells. The mechanism may be related to down-regulation of the MDR1 gene transcription and the P-gp mediated drug e?ux function.

Reversal of Resistance to Adriamycin in Human Breast Cancer Cell MCF-7/ADM by Genistein

[Reversal Effect and Its Mechanism of (- )-5-n-acetylardeemin on Adriamycin Resistance in Multidrug-Resistant Cancer Cells A549/Adr and MCF-7/Adr].

[Inhibitory effect of ZD6474 combined with adriamycin on MCF-7 human breast cancer cells in vitro].

Reversal in Multidrug Resistance by Magnetic Nanoparticle of Fe3o4 Loaded with Adriamycin and Tetrandrine in K562/A02 Leukemic Cells

Reversal effect of toremifene and tamoxifen on multidrug resistance in MCF7/ADR cell

Reversal Effects of Milbemycins on Multidrug Resistance in MCF-7/adr Cells

Effect of apigenin on the multidrug resistant breast cancer cell line MCF-7/ADR

Synergistic Effects of TOR Combined with EADM on Growth and Apoptosis in Human Lung Cancer Cell Lines A549 and H1299

Molecular Mechanism of Reversal Effect of Monoclonal Antibody to Basic Fibroblast Growth Factor-Mediated Expression of P-glycoprotein on Multiple Drug Resistance in Adriamycin-Resistant Human Breast Cancer Cell Line MCF-7/ADM

Inhibitory Effect of Combined Herceptin and Adriamycin on Human Breast Cancer Cells

Reverse offect of miR-7 on adriamycin resistance of breast cancer cells

REVERSAL EFFECTS OF MIFEPRISTONE ON MULTIDRUG RESISTANCE（MDR） IN DRUG-RESISTANT BREAST CANCER CELL LINE MCF7/ADR IN VITRO AND IN VIVO

Reversal of Grape Seed Polyphenol on Multidrug Resistance of MCF-7/ADR in Vitro and in Vivo

Synergistic Antitumor Effect of TRAIL and Adriamycin on the Human Breast Cancer Cell Line MCF-7.

Effect of Tetrandrine and Toremifene on the Reversion of Multidrug Resistance of K562/A02 Cell Line

[Inhibitory and Apoptosis Regulating Effects of Adriamycin on Different Human Breast Cancer Cell Lines].

A dynamic study on reversal of multidrug resistance by ginsenoside Rh₂ in adriamycin-resistant human breast cancer MCF-7 cells.

Effect on the Expression of P-glyeoprotein,extracellular Matrix Metalloproteinase Inducer,and Matrix Metalloproteinase in Multidrug Resistant Breast Cancer Cells Treated with Gensenoside Rh_2

Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7/Adr cells.

Ophiobolin-O Reverses Adriamycin Resistance Via Cell Cycle Arrest and Apoptosis Sensitization in Adriamycin-Resistant Human Breast Carcinoma (MCF-7/ADR) Cells

Effect of Tetrandrine,Toremifene and Their Combination on the Reversion of Multidrug Resistance of K562/A02 Cell Line